(19)

(11)

EP 4 770 669 A2

(12)

(88) Date of publication A3: 10.04.2025 (43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24765401.5 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  A61K 39/215(2006.01) C07K 14/165(2006.01) A61P 31/14(2006.01) (52) Cooperative Patent Classification (CPC): A61K 39/215; C12N 2770/20034; A61K 2039/57; A61K 2039/70; A61P 31/14; C07K 14/005; C12N 2770/20022 (86) International application number: PCT/EP2024/074380 (87) International publication number: WO 2025/046130 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.09.2023 GB 202313360 (71) Applicant: NEC OncoImmunity AS 0379 Oslo (NO)	(72) Inventors: MALONE, Brandon 0379 Oslo (NO) GHEORGHE, Marius 0379 Oslo (NO) CLANCY, Trevor 0379 Oslo (NO) STRATFORD, Richard 0379 Oslo (NO) BENDJAMA, Kaidre 0379 Oslo (NO) (74) Representative: Gill Jennings & Every LLP  The Broadgate Tower 20 Primrose Street London EC2A 2ES London EC2A 2ES (GB)